TruDiagnostic TruAge

What Is TruDiagnostic TruAge?

TruDiagnostic TruAge is an epigenetic biological age test that measures how your DNA methylation patterns compare to population-level aging data. Unlike blood biomarker panels (InsideTracker, Function Health) that assess your current health status through circulating markers, TruAge examines epigenetic modifications to your DNA — chemical tags that accumulate with age and environmental exposure — to estimate both your current biological age and your pace of aging.

Founded in 2020 and based in Lexington, Kentucky, TruDiagnostic has positioned itself as the leading consumer-facing epigenetic testing company. The TruAge COMPLETE kit (~$499) uses at-home blood spot collection and analyzes over 900,000 methylation sites across your genome.

How It Works

Epigenetic aging is grounded in the discovery that specific sites on your DNA accumulate methyl groups (chemical tags) in predictable patterns as you age. Dr. Steve Horvath's 2013 landmark paper in Genome Biology established the first "epigenetic clock" — a mathematical model that estimates biological age from methylation patterns at specific DNA sites. Since then, multiple refined clocks have been developed, each capturing different aspects of aging.

TruAge COMPLETE reports results from several validated epigenetic clocks:

• Horvath Clock: The original multi-tissue epigenetic clock, estimating biological age from 353 CpG sites
• Hannum Clock: A blood-based clock using 71 CpG sites, often considered more sensitive to recent health changes
• DunedinPACE: Developed from the Dunedin longitudinal birth cohort study, this measures the pace of aging — how fast you are aging right now — rather than a static biological age snapshot. A 2022 study in Nature Aging validated DunedinPACE as a predictor of future morbidity and mortality
• GrimAge: Correlates with lifespan and healthspan predictions based on methylation surrogates of plasma proteins

The at-home collection process uses a dried blood spot card — you prick your finger, fill several circles on the card, and mail it to TruDiagnostic's CLIA-certified lab. Results arrive in 4-6 weeks.

Key Features

• Multi-clock reporting: Results from Horvath, Hannum, DunedinPACE, GrimAge, and proprietary clocks provide a multidimensional view of biological aging
• Pace of aging (DunedinPACE): Measures your current rate of aging, not just a snapshot — arguably the most actionable metric for intervention tracking
• 900,000+ methylation sites analyzed: Comprehensive epigenomic coverage using Illumina methylation array technology
• At-home blood spot collection: No lab visit required; finger-prick sample mailed to CLIA-certified lab
• Longitudinal tracking: Retesting every 6-12 months reveals whether lifestyle interventions are measurably slowing biological aging

Our Testing Experience

The collection process was simple — the kit includes a lancet, blood spot card, detailed instructions with photographs, and a prepaid return mailer. The finger prick is quick, though filling the blood spot circles completely requires a bit more blood than some finger-prick tests; we found warming the hands under hot water for two minutes beforehand helped significantly with blood flow. Results took approximately five weeks, which is substantially longer than blood biomarker services (5-10 days) but standard for methylation array processing.

The results dashboard presents multiple biological age estimates, which can initially be confusing. Our tester received a Horvath age of 31 (chronological age 35), a DunedinPACE score of 0.87 (where 1.0 represents average pace of aging), and a GrimAge of 33. Each clock uses different CpG sites and mathematical models, so discrepancies between them are expected and informative rather than contradictory. Understanding what each clock measures and why they differ requires reading TruDiagnostic's educational materials — the platform does provide detailed explanations and comparison charts, but the learning curve is steeper than a straightforward blood panel.

The most compelling metric is DunedinPACE: a score below 1.0 means you are aging slower than average, above 1.0 means faster. This creates a clear and motivating optimization target. For context, research on the Dunedin cohort found that DunedinPACE scores correlated with physical function decline, cognitive aging, and facial aging — individuals with lower scores looked and functioned younger than their chronological age would predict. Our tester's 0.87 score suggested a pace of aging roughly 13% slower than average, which aligned with their active lifestyle and strong sleep habits.

However, it is important to note that while epigenetic clocks are supported by rigorous research, the field is still evolving. Methylation patterns can be influenced by acute factors (illness, stress, poor sleep, recent intense exercise) that may not reflect long-term aging trajectory. A single elevated DunedinPACE score after a bout of illness does not necessarily indicate accelerated long-term aging. TruDiagnostic recommends retesting after 6-12 months of consistent lifestyle changes rather than reacting to a single test, and we strongly agree with this guidance.

The Bottom Line

TruDiagnostic TruAge represents the most scientifically rigorous consumer-facing biological age test available, grounded in peer-reviewed epigenetic clock research from Horvath, Hannum, and the Dunedin longitudinal study. The DunedinPACE metric — measuring pace of aging rather than a static snapshot — is uniquely valuable for tracking whether longevity interventions are working. The tradeoff is complexity: multiple clock results require interpretation, results take 4-6 weeks, and the $499 price point makes frequent retesting a significant investment. Best suited for longevity-focused individuals who understand that epigenetic age testing complements, rather than replaces, standard blood biomarker panels.